N/A
Completed N=40
Efficacy of Adhesive Strength of New Hydrogel Formulation
Stroke, Acute
Source: ClinicalTrials.gov NCT04309110 ↗
Enrolled (actual)
40
Serious AEs
0.0%
Results posted
Feb 2024
Primary outcomePrimary: Efficacy of the Skin Adhesive Strength of Hydrogel KM40C Compared to That of Hydrogel KM10T. — 1.52; 1.23 score on a scale
Summary
The study will look at the stickiness of a new skin adhesive incorporated into a new next generation geko™ device called the geko™ X-T3 and compare it to the adhesive currently used into the geko™ T3 device. The study is for people who are in hospital in the Acute Stroke Unit, and who will be receiving daily treatment with the geko™ T3 device in line with UK guidelines as part of their standard acute stroke care and venous thromboembolism prevention.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Efficacy of the Skin Adhesive Strength of Hydrogel KM40C Compared to That of Hydrogel KM10T. |
1.52; 1.23 | — |
| SECONDARY Incidence of Adverse Events |
— | — |
Eligibility Criteria
Inclusion Criteria
- Male or female aged ≥ 18 years
- Currently an in-patient hospitalised for acute stroke
- Use of geko™ as a mechanical prophylaxis strategy for venous thromboembolism
- Patient understands and is willing to participate in the study and is able to comply with study procedures
Exclusion Criteria
- Pregnancy or breast feeding
- Use of any neuro-modulation device other than geko™
- Participation in any other clinical study that may interfere with the outcome of either study
Data sourced from ClinicalTrials.gov (NCT04309110). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.